[1]
Mahmoud, R. et al. 2023. A severe case of Pembrolizumab-induced triad of myasthenic crisis, myocarditis, and anti-SSA myositis. RRNMF Neuromuscular Journal. 4, 4 (Sep. 2023). DOI:https://doi.org/10.17161/rrnmf.v4i4.19844.